Myeloid ELF-1-like factor up-regulates lysozyme transcription in epithelial cells

被引:33
作者
Kai, H
Hisatsune, A
Chihara, T
Uto, A
Kokusho, A
Miyata, T
Basbaum, C
机构
[1] Kumamoto Univ, Fac Pharmaceut Sci, Dept Pharmacol Sci, Kumamoto 862, Japan
[2] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
关键词
D O I
10.1074/jbc.274.29.20098
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lysozyme is an important component of innate immunity against common pathogens at mucosal surfaces. We previously cloned and characterized the bovine lysozyme 5A (lys5A) promoter with the purpose of determining cis- anal trans-acting elements controlling airway epithelial cell-specific expression. We found that such expression is controlled by protein binding to an ETS consensus sequence located approximately at -46 to -40 bp from the transcription start site. The identity of the ETS-related protein responsible for gene transactivation was unknown. In this study, we screened six ETS-related proteins by transient transfection into epithelial cells and fibroblasts. Results showed that among these factors, the myeloid Elf-1-like factor (MEF) was the most potent. Gel shift analysis of epithelial cell nuclear extracts using a lys5A probe including the ETS-binding site (-50/-31) yielded a single band with retarded mobility. This band was supershifted by an antibody directed against MEF. Supporting the possibility that MEF is responsible for functional transactivation of lysozyme in epithelial cells, we found that antisense MEF mRNA decreased lys5A promoter activity and that MEF overexpression in stably transfected cells increased lysozyme mRNA and protein expression, We conclude that MEF is required for epithelial cell transactivation of lysozyme.
引用
收藏
页码:20098 / 20102
页数:5
相关论文
共 33 条
[21]   DISTRIBUTION OF MURAMIDASE (LYSOZYME) IN HUMAN TISSUES [J].
MASON, DY ;
TAYLOR, CR .
JOURNAL OF CLINICAL PATHOLOGY, 1975, 28 (02) :124-132
[22]  
Miyazaki Y, 1996, ONCOGENE, V13, P1721
[23]   DEFECTIVE ACTIVATION AND SURVIVAL OF T-CELLS LACKING THE ETS-1 TRANSCRIPTION FACTOR [J].
MUTHUSAMY, N ;
BARTON, K ;
LEIDEN, JM .
NATURE, 1995, 377 (6550) :639-642
[24]   Methylation of the mouse M-lysozyme downstream enhancer inhibits heterotetrameric GABP binding [J].
Nickel, J ;
Short, ML ;
Schmitz, A ;
Eggert, M ;
Rankawitz, R .
NUCLEIC ACIDS RESEARCH, 1995, 23 (23) :4785-4792
[25]   Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family [J].
Oettgen, P ;
Alani, RM ;
Barcinski, MA ;
Brown, L ;
Akbarali, Y ;
Boltax, J ;
Kunsch, C ;
Munger, K ;
Libermann, TA .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (08) :4419-4433
[26]   The novel epithelial-specific Ets transcription factor gene ESX maps to human chromosome 1q32.1 [J].
Oettgen, P ;
Carter, KC ;
Augustus, M ;
Barcinski, M ;
Boltax, J ;
Kunsch, C ;
Libermann, TA .
GENOMICS, 1997, 45 (02) :456-457
[27]   REQUIREMENT OF TRANSCRIPTION FACTOR PU.1 IN THE DEVELOPMENT OF MULTIPLE HEMATOPOIETIC LINEAGES [J].
SCOTT, EW ;
SIMON, MC ;
ANASTASI, J ;
SINGH, H .
SCIENCE, 1994, 265 (5178) :1573-1577
[28]   Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid [J].
Smith, JJ ;
Travis, SM ;
Greenberg, EP ;
Welsh, MJ .
CELL, 1996, 85 (02) :229-236
[29]   A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer [J].
Tymms, MJ ;
Ng, AYN ;
Thomas, RS ;
Schutte, BC ;
Zhou, JO ;
Eyre, HJ ;
Sutherland, GR ;
Seth, A ;
Rosenberg, M ;
Papas, T ;
Debouck, C ;
Kola, I .
ONCOGENE, 1997, 15 (20) :2449-2462
[30]   THE ETS FAMILY OF TRANSCRIPTION FACTORS [J].
WASYLYK, B ;
HAHN, SJL ;
GIOVANE, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 211 (1-2) :7-18